生命科学资讯

ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma

ASH: Novartis details ianalumab's phase 3 win in rare blood disease

Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug

Ose narrows focus to conserve cash at expense of wider pipeline

ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma

Pfizer dips into China for another try at an obesity pill

Stealthy biotech Sidera Bio raises $109M; Assembly's data for oral herpes drugs

Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Market, 2025-2033: Insights by Service, Product, End-Use and Region - ResearchAndMarkets.com - The AI Journal

FDA raises CAR-T approval standards; Novartis bets on an AI startup

Seven biotechs eye $2.3B in public offerings after data readouts

ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data

NeurIPS 2025: Biology’s Transformer Moment - Genetic Engineering and Biotechnology News

Radial raises $50M to treat mental health in non-traditional ways

Male bonobo mating strategies target female fertile windows despite noisy ovulatory signals during sexual swelling

The luminal ring protein C2CD3 acts as a radial in-to-out organizer of the distal centriole and appendages

GSK goes away, Ideaya synthetic lethality bids in-house again

Accelerating Drug Discovery at Grove Biopharma with MyGlo® and ProNect®

Ossiam Sells 3,400 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Here Are Tuesday's Top Wall Street Analyst Research Calls: Agilent, Alibaba, Delta Air Lines, Intel, JD.com, Micron Technology, Reddit and More - 24/7 Wall St.

Agilent Technologies (A) Receives Buy Rating from Goldman Sachs | A Stock News - GuruFocus